Evaluation of Human Serum Albumin Nanoparticles for Rapamycin Delivery.

Rodero CF, Pangua C, Gracia JM, Suner MB, Guiguer MT, Chorilli M, Irache JM

DOI: 10.1021/acsomega.6c02977
Published: 2026 Aug 18
Container: ACS omega
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.6c02977,
  title = {Evaluation of Human Serum Albumin Nanoparticles for Rapamycin Delivery.},
  author = {Rodero CF and Pangua C and Gracia JM and Suner MB and Guiguer MT and Chorilli M and Irache JM},
  year = {2026},
  journal = {ACS omega},
  doi = {10.1021/acsomega.6c02977},
  url = {https://doi.org/10.1021/acsomega.6c02977}
}

RIS

TY  - JOUR
TI  - Evaluation of Human Serum Albumin Nanoparticles for Rapamycin Delivery.
AU  - Rodero CF
AU  - Pangua C
AU  - Gracia JM
AU  - Suner MB
AU  - Guiguer MT
AU  - Chorilli M
AU  - Irache JM
PY  - 2026
JO  - ACS omega
DO  - 10.1021/acsomega.6c02977
UR  - https://doi.org/10.1021/acsomega.6c02977
ER  -

APA

CF, R., C, P., JM, G., MB, S., MT, G., M, C., & JM, I. (2026). Evaluation of Human Serum Albumin Nanoparticles for Rapamycin Delivery.. ACS omega. https://doi.org/10.1021/acsomega.6c02977

Source records

pubmed · retrieved 2026-09-25T15:28:01.148Z